Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4799891
Max Phase: Preclinical
Molecular Formula: C55H73N15O9
Molecular Weight: 1088.29
Molecule Type: Unknown
Associated Items:
ID: ALA4799891
Max Phase: Preclinical
Molecular Formula: C55H73N15O9
Molecular Weight: 1088.29
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCCNC(=N)N)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O
Standard InChI: InChI=1S/C55H73N15O9/c1-3-4-16-41(64-32(2)71)49(74)70-46-28-47(72)60-22-11-9-18-40(48(56)73)65-52(77)44(26-36-29-62-39-17-8-7-15-38(36)39)68-50(75)42(19-10-12-23-61-55(57)58)66-51(76)43(25-33-20-21-34-13-5-6-14-35(34)24-33)67-53(78)45(69-54(46)79)27-37-30-59-31-63-37/h5-8,13-15,17,20-21,24,29-31,40-46,62H,3-4,9-12,16,18-19,22-23,25-28H2,1-2H3,(H2,56,73)(H,59,63)(H,60,72)(H,64,71)(H,65,77)(H,66,76)(H,67,78)(H,68,75)(H,69,79)(H,70,74)(H4,57,58,61)/t40-,41-,42-,43+,44-,45-,46-/m0/s1
Standard InChI Key: VJUGSZWVYVMRBR-WSUOKSENSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1088.29 | Molecular Weight (Monoisotopic): 1087.5716 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Martin C,Gimenez LE,Williams SY,Jing Y,Wu Y,Hollanders C,Van der Poorten O,Gonzalez S,Van Holsbeeck K,Previti S,Lamouroux A,Zhao S,Tourwé D,Stevens RC,Cone RD,Ballet S. (2021) Structure-Based Design of Melanocortin 4 Receptor Ligands Based on the SHU-9119-hMC4R Cocrystal Structure†., 64 (1.0): [PMID:33190475] [10.1021/acs.jmedchem.0c01620] |
Source(1):